Although patients with detectable pre‐treatment levels of circulating HPV‐DNA had worse progression‐free survival than patients without detectable circulating HPV‐DNA, this difference did not reach statistical significance.
← all excerpts
Circulating Tumor HPV-DNA in the Management of HPV-Positive Oropharyngeal Carcinoma: A Systematic Review.
1
—
—